+1 862-686-2696
Featured Products
Primary Cells
Immortalized Cell Lines
Stem Cells
Tumor Cell Lines
Transfected Stable Cell Lines
Exosomes
MicroRNA Agomir/Antagomir
Nucleic Acid Kits
Explore Products
Cell
Cell
MicroRNA
MicroRNA
Test and Analysis
Test and Analysis
Tumor Cell Lines

CTX TNA2

  • BSL

    1

  • 345
Rat Astrocyte, Transfected. Established by transfecting cultures of primary astrocytes from brain frontal cortex tissue of 1 day old sprague-dawley rats with a DNA construct containing the oncogenic early region of SV40.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Home | Tumor Cell Lines | Animal Tumor Cell Lines | CTX TNA2
Species

Rattus Norvegicus
Cat.No

ABC-TC0199
Product Category Tumor Cell Lines
Size/Quantity

1 vial
Cell Type

Fibroblast
Shipping Info

Dry Ice
Growth Conditions

37 ℃, 5% CO2
Source Organ

Brain
Disease

Normal
Biosafety Level

1
Storage

Liquid Nitrogen
Product Type

Rat Nerve Tumors Cell Lines

Description

CTX-TNA2 rat type I astrocyte cells exhibit fibroblast-like morphology in adherent culture; Scale bar at bottom right.
CTX TNA2 is a transformed type I astrocyte cell line derived from the frontal cortex tissue of a neonate Sprague-Dawley rat. This transformed cell line exhibits fibroblast-like morphology and adherent growth properties, with a doubling time of approximately 40–50 hours under standard culture conditions. CTX TNA2 was generated by transfecting the SV40 early region oncogene under the control of the human glial fibrillary acidic protein (GFAP) promoter, ensuringastrocyte lineage specificity. This genetic modification leads to stable expression of SV40 T-antigen in over 95% of cells. Despite transformation, approximately 20% of CTX TNA2 cells retain GFAP expression, a hallmark for astrocytic identity. While the cell line lacks type II astrocyte markers (O4/A2B5) and shows reduced transferrin production compared to primary astrocytes. CTX TNA2 is non-tumorigenic in immunocompromised mice. This cell line serves as a valuable model for studying astrocyte functions in neurological research.

AcceGen Frozen Cells & Cell Lines

AcceGen product mpp-89 cell line

View Product Image

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • CTX TNA2 serves as a robust and reproducible model for neuroscience and neurobiological research, particularly in studies related to astrocyte biology, central nervous system (CNS) development, and glial cell signaling. It plays a pivotal role in elucidating the biochemical and physiological properties of astrocytes under controlled conditions. When co-cultured with primary porcine brain endothelial cells, CTX TNA2 contributes to the formation of in vitro blood-brain barrier (BBB) models, enabling the study of BBB function, integrity, and permeability. These models are instrumental in drug delivery, neuroinflammation, and neuropharmacology research, making CTX TNA2 a valuable tool for advancing our understanding of brain homeostasis and therapeutic strategies targeting the CNS.

  • Online Inquiry
  • Product Reviews

Inquiring CTX TNA2

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

Let's Advance Life Science Research Together

Contact Us
AcceGen Scroll Top Button